Spectral domain optical coherence tomography as an effective screening test for hydroxychloroquine retinopathy (the "flying saucer" sign)
- PMID: 21060664
- PMCID: PMC2964950
- DOI: 10.2147/OPTH.S14257
Spectral domain optical coherence tomography as an effective screening test for hydroxychloroquine retinopathy (the "flying saucer" sign)
Abstract
Purpose: While the long-term incidence of hydroxychloroquine (HCQ) retinopathy is low, there remains no definitive clinical screening test to recognize HCQ toxicity before ophthalmoscopic fundus changes or visual symptoms. Patients receiving HCQ were evaluated with spectral domain optical coherence tomography (SD OCT) to assess the feasibility of identifying HCQ retinopathy at an early stage.
Methods: Twenty-five patients referred for the evaluation of hydroxychloroquine toxicity underwent a comprehensive ocular examination, Humphrey visual field (HVF) perimetry, time domain OCT, and SD OCT. Some patients with screening abnormalities also underwent further diagnostic testing at the discretion of the treating providers.
Results: Five patients were found to have SD OCT findings corresponding to HCQ toxicity and retinal damage as seen by clinical exam and/or HVF perimetry. Two patients with advanced toxicity were found to have significant outer retina disruption in the macula on SD OCT. Three patients with early HCQ toxicity and HVF 10-2 perifoveal defects were found to have loss of the perifoveal photoreceptor inner segment/outer segment (IS/OS) junction with intact outer retina directly under the fovea, creating the "flying saucer" sign. While two of these three patients had early ophthalmoscopic fundus changes, one had none.
Conclusion: Outer retinal abnormalities including perifoveal photoreceptor IS/OS junction disruption can be identified by SD OCT in early HCQ toxicity, sometimes even before ophthalmoscopic fundus changes are apparent. SD OCT may have a potential complementary role in screening for HCQ retinopathy due to its quick acquisition and because it is more objective than automated perimetry.
Keywords: drug toxicity; hydroxychloroquine; photoreceptors; screening test; spectral domain optical coherence tomography.
Figures




Similar articles
-
Spectral-domain optical coherence tomography and adaptive optics may detect hydroxychloroquine retinal toxicity before symptomatic vision loss.Trans Am Ophthalmol Soc. 2009 Dec;107:28-33. Trans Am Ophthalmol Soc. 2009. PMID: 20126479 Free PMC article.
-
Early hydroxychloroquine retinopathy: optical coherence tomography abnormalities preceding Humphrey visual field defects.Br J Ophthalmol. 2019 Nov;103(11):1600-1604. doi: 10.1136/bjophthalmol-2018-313350. Epub 2019 Feb 28. Br J Ophthalmol. 2019. PMID: 30819690
-
Spectral-Domain Optical Coherence Tomography Is More Sensitive for Hydroxychloroquine-Related Structural Abnormalities Than Short-Wavelength and Near-Infrared Autofluorescence.Transl Vis Sci Technol. 2020 Aug 5;9(9):8. doi: 10.1167/tvst.9.9.8. eCollection 2020 Aug. Transl Vis Sci Technol. 2020. PMID: 32879764 Free PMC article.
-
Evaluation of changes in thickness of macular sublayers in patients using Hydroxychloroquine: a cross sectional case-control study and literature review.Cutan Ocul Toxicol. 2025 Mar;44(1):55-62. doi: 10.1080/15569527.2024.2438629. Epub 2024 Dec 16. Cutan Ocul Toxicol. 2025. PMID: 39680032 Review.
-
Review of Retinal Imaging Modalities for Hydroxychloroquine Retinopathy.Diagnostics (Basel). 2023 May 16;13(10):1752. doi: 10.3390/diagnostics13101752. Diagnostics (Basel). 2023. PMID: 37238236 Free PMC article. Review.
Cited by
-
Clinical applications of spectral domain optical coherence tomography in retinal diseases.Biomed J. 2016 Apr;39(2):107-20. doi: 10.1016/j.bj.2016.04.003. Epub 2016 Jun 20. Biomed J. 2016. PMID: 27372166 Free PMC article. Review.
-
Bull's eye maculopathy and subfoveal deposition in two mucopolysaccharidosis type I patients on long-term enzyme replacement therapy.Am J Ophthalmol Case Rep. 2017 Oct 4;9:1-6. doi: 10.1016/j.ajoc.2017.10.006. eCollection 2018 Mar. Am J Ophthalmol Case Rep. 2017. PMID: 29468207 Free PMC article.
-
Scotoma analysis of 10-2 visual field testing with a red target in screening for hydroxychloroquine retinopathy.Clin Ophthalmol. 2015 Aug 20;9:1499-509. doi: 10.2147/OPTH.S87850. eCollection 2015. Clin Ophthalmol. 2015. PMID: 26316692 Free PMC article.
-
Advanced pentosan polysulfate sodium maculopathy with low cumulative exposure and hydroxychloroquine use.Am J Ophthalmol Case Rep. 2024 Nov 22;36:102224. doi: 10.1016/j.ajoc.2024.102224. eCollection 2024 Dec. Am J Ophthalmol Case Rep. 2024. PMID: 39691632 Free PMC article.
-
Quantitative Fundus Autofluorescence in HCQ Retinopathy.Invest Ophthalmol Vis Sci. 2020 Sep 1;61(11):41. doi: 10.1167/iovs.61.11.41. Invest Ophthalmol Vis Sci. 2020. PMID: 32976563 Free PMC article.
References
-
- Mavrikakis I, Sfikakis PP, Mavrikakis E, et al. The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal. Ophthalmology. 2003;110(7):1321–1326. - PubMed
-
- Levy GD, Munz SJ, Paschal J, Cohen HB, Pince KJ, Peterson T. Incidence of hydroxychloroquine retinopathy in 1,207 patients in a large multicenter outpatient practice. Arthritis Rheum. 1997;40(8):1482–1486. - PubMed
-
- Marmor MF, Carr RE, Easterbrook M, Farjo AA, Mieler WF. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology. Ophthalmology. 2002;109(7):1377–1382. - PubMed
-
- Marmor MF. The dilemma of hydroxychloroquine screening: new information from the multifocal ERG. Am J Ophthalmol. 2005;140(5):894–895. - PubMed
LinkOut - more resources
Full Text Sources